AI-generated summary
This prospective cohort study of 28 menopausal patients treated for cancer, who had not responded to first-line treatment, reports that photobiomodulation was associated with improvement in vulvovaginal symptoms. The authors report that 72% of patients felt better or much better after treatment. The authors note the small, heterogeneous sample and lack of a control group, so they say their results cannot be extrapolated.
- Participants
- 28
- Who or what was studied
- Menopausal patients treated for cancer with vulvovaginal disorders who failed first-line medical treatment, managed at the University Hospital of Nîmes
- Limits stated in the abstract
- The abstract states the sample was small and heterogeneous with no control group, so results cannot be extrapolated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.